Lunai Bioworks LNAI
NASDAQ LNAI
$1.77 -0.07 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Revenue (2013 - 2026)

Updated

Lunai Bioworks' Revenue was $20,942 in fiscal Q3 2026 (quarter ended Mar 31, 2026).

Analysis

Lunai Bioworks (LNAI) Revenue (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Lunai Bioworks' Revenue was $85,227 through Mar 31, 2026; for FY2016 (ended Jun 30, 2016), it came in at $42,769.

  • Revenue shows a four-year compound annual growth rate of -9.2% (FY2012 to FY2016).
  • In earlier fiscal years, Revenue was $42,525 in FY2015, $32,768 in FY2013 (-47.8%) and $62,806 in FY2012.
  • The fiscal Q3 2026 figure marks the highest quarterly Revenue since fiscal Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Lunai Bioworks 5.81 Mn 1.06 Mn 20,942.00 20,942.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 20,942.00
Dec 31, 2015 42,525.00
Sep 30, 2013 925.00
Mar 31, 2013 31,558.00
API Access

Lunai Bioworks Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=LNAI&period=max&api_key=YOUR_API_KEY